GC
Therapeutic Areas
Innosphera Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ING-006 | Idiopathic Pulmonary Fibrosis | Preclinical |
| ING-008 | Cardiometabolic (Obesity, MASH) | Preclinical |
| ING-Series | Various cardiometabolic and chronic inflammatory conditions | Preclinical |
Leadership Team at Innosphera Pharma
PL
Pierre Laurin
Executive Chairman
FR
François Ravenelle
President and CEO
LG
Lyne Gagnon
Chief Scientific Officer